THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $683,000 | -0.4% | 21,411 | +13.1% | 0.00% | 0.0% |
| Q3 2016 | $686,000 | +90.0% | 18,931 | +18.9% | 0.00% | – |
| Q2 2016 | $361,000 | +47.3% | 15,919 | +22.1% | 0.00% | – |
| Q1 2016 | $245,000 | +23.1% | 13,033 | +7.4% | 0.00% | – |
| Q4 2015 | $199,000 | +11.8% | 12,140 | -25.0% | 0.00% | – |
| Q3 2015 | $178,000 | -18.3% | 16,177 | -3.4% | 0.00% | – |
| Q2 2015 | $218,000 | -18.4% | 16,749 | +8.7% | 0.00% | – |
| Q1 2015 | $267,000 | +37.6% | 15,410 | +18.7% | 0.00% | – |
| Q4 2014 | $194,000 | -38.2% | 12,983 | -4.8% | 0.00% | – |
| Q3 2014 | $314,000 | -29.3% | 13,633 | -2.1% | 0.00% | – |
| Q2 2014 | $444,000 | – | 13,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |